ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹637 Cr | ₹625 Cr | ₹604 Cr | ₹512 Cr | ₹475 Cr |
What is the latest Total Liabilities ratio of ALBERT DAVID ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹637 Cr |
| Mar2025 | ₹625 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹512 Cr |
| Mar2022 | ₹475 Cr |
How is Total Liabilities of ALBERT DAVID Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹637 Cr | 1.93 | |
| Mar2025 | ₹625 Cr | 3.34 | |
| Mar2024 | ₹604 Cr | 17.98 | |
| Mar2023 | ₹512 Cr | 7.82 | |
| Mar2022 | ₹475 Cr | - | |
Compare Total Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹496.1 Cr | 2.7% | 0% | 9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 2.7% |
0% |
9.1% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses